213 related articles for article (PubMed ID: 20015465)
21. Generation of a transgenic animal model of hyperthyroid Graves' disease.
Kim-Saijo M; Akamizu T; Ikuta K; Iida Y; Ohmori K; Matsubara K; Matsuda Y; Suzuki M; Matsuda F; Nakao K
Eur J Immunol; 2003 Sep; 33(9):2531-8. PubMed ID: 12938229
[TBL] [Abstract][Full Text] [Related]
22. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.
Tsui S; Naik V; Hoa N; Hwang CJ; Afifiyan NF; Sinha Hikim A; Gianoukakis AG; Douglas RS; Smith TJ
J Immunol; 2008 Sep; 181(6):4397-405. PubMed ID: 18768899
[TBL] [Abstract][Full Text] [Related]
23. Effect of Graves' intrathyroidal lymphocytes. Effect of Graves' disease intrathyroidal lymphocytes (ITL) on xenotransplants of human thyroid tissue in athymic nude mice.
Schumm-Draeger PM; Jungheim K; Caspar G; Hermann G; Fortmeyer HP; Wenisch HJ; Usadel KH
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():60-3. PubMed ID: 8981004
[TBL] [Abstract][Full Text] [Related]
24. Autoimmune thyrotoxicosis: diagnostic challenges.
Ponto KA; Kahaly GJ
Am J Med; 2012 Sep; 125(9):S1. PubMed ID: 22938935
[TBL] [Abstract][Full Text] [Related]
25. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
[TBL] [Abstract][Full Text] [Related]
26. Immunization of mice with a newly identified thyroid-stimulating hormone receptor splice variant induces Graves'-like disease.
Endo T; Kobayashi T
J Autoimmun; 2013 Jun; 43():18-25. PubMed ID: 23538203
[TBL] [Abstract][Full Text] [Related]
27. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
28. TSH receptor protein is selectively expressed in normal human extraocular muscle.
Kloprogge SJ; Busuttil BE; Frauman AG
Muscle Nerve; 2005 Jul; 32(1):95-8. PubMed ID: 15779008
[TBL] [Abstract][Full Text] [Related]
29. Elevated follicular helper T cells and expression of IL-21 in thyroid tissues are involved in the pathogenesis of Graves' disease.
Zhang J; Ren M; Zeng H; Guo Y; Zhuang Z; Feng Z; Yan H; Xu M; Liang W; Yang C; Cheng H; Ding H; Yan L
Immunol Res; 2015 Jun; 62(2):163-74. PubMed ID: 25894310
[TBL] [Abstract][Full Text] [Related]
30. Asialoagalacto-human chorionic gonadotropin, a carbohydrate-modified variant of human chorionic gonadotropin, antagonizes the stimulatory actions of bovine thyroid-stimulating hormone on thyroid function and HLA-DR expression in human thyroid in vitro and in vivo.
Hoermann R; Schumm-Draeger PM; Rehbach K; Mann K
J Clin Invest; 1991 Dec; 88(6):1947-54. PubMed ID: 1752954
[TBL] [Abstract][Full Text] [Related]
31. Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production.
Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1988 Aug; 11(4):279-85. PubMed ID: 3262474
[TBL] [Abstract][Full Text] [Related]
32. Peptides presented in vivo by HLA-DR in thyroid autoimmunity.
Muixí L; Alvarez I; Jaraquemada D
Adv Immunol; 2008; 99():165-209. PubMed ID: 19117535
[TBL] [Abstract][Full Text] [Related]
33. Functional expression of thyroid-stimulating hormone receptor on nano-sized bacterial magnetic particles in Magnetospirillum magneticum AMB-1.
Sugamata Y; Uchiyama R; Honda T; Tanaka T; Matsunaga T; Yoshino T
Int J Mol Sci; 2013 Jul; 14(7):14426-38. PubMed ID: 23852019
[TBL] [Abstract][Full Text] [Related]
34. Tumour necrosis factor synergises with gamma interferon on the induction of mRNA for DR alpha chain on thyrocytes from Graves' disease and non toxic goitre.
Kissonerghis AM; Grubeck-Loebenstein B; Pirich K; Feldmann M; Londei M
Autoimmunity; 1989; 4(4):255-66. PubMed ID: 2518829
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of metallothionein I/II: a new feature of thyroid follicular cells in Graves' disease.
Ruiz-Riol M; Martínez-Arconada MJ; Alonso N; Soldevila B; Marchena D; Armengol MP; Sanmartí A; Pujol-Borrell R; Martínez-Cáceres EM
J Clin Endocrinol Metab; 2012 Feb; 97(2):446-54. PubMed ID: 22090273
[TBL] [Abstract][Full Text] [Related]
36. The genetics of the thyroid stimulating hormone receptor: history and relevance.
Davies TF; Yin X; Latif R
Thyroid; 2010 Jul; 20(7):727-36. PubMed ID: 20578897
[TBL] [Abstract][Full Text] [Related]
37. Expression of HLA-DR antigens by thyroid cells: the effect of Graves' IgG.
Bodolay E; Szegedi G; Suranyi P; Juhasz F; Stenszky V; Balazs C; Farid NR
Immunol Lett; 1987 May; 15(1):77-81. PubMed ID: 3111991
[TBL] [Abstract][Full Text] [Related]
38. Graves' hyperthyroidism and thyroiditis in HLA-DRB1*0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA.
Flynn JC; Rao PV; Gora M; Alsharabi G; Wei W; Giraldo AA; David CS; Banga JP; Kong YM
Clin Exp Immunol; 2004 Jan; 135(1):35-40. PubMed ID: 14678262
[TBL] [Abstract][Full Text] [Related]
39. c-myc expression is associated with increased proliferation activity in thyroid follicular cells of Graves' disease as stimulated by autoantibodies.
Kashima K; Yokoyama S; Daa T; Takahashi K; Nakayama I; Noguchi S
Eur J Endocrinol; 1996 Jul; 135(1):69-76. PubMed ID: 8765976
[TBL] [Abstract][Full Text] [Related]
40. A Modifying Autoantigen in Graves' Disease.
Latif R; Mezei M; Morshed SA; Ma R; Ehrlich R; Davies TF
Endocrinology; 2019 May; 160(5):1008-1020. PubMed ID: 30822352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
